Skip to main content
. 2019 May 2;39(5):BSR20181016. doi: 10.1042/BSR20181016

Table 1. Associations between tissue HMGB1 expression and clinicopathologic characteristics of cervical cancer patients.

Variables HMGB1 expression (n (%)) Total N χ2 P-value
High 5–7 Low 0–4
Age at diagnosis (years) 0.262 0.609
  <40 47 (57.3) 35 (42.7) 82
  ≥40 84 (53.5) 73 (46.5) 157
Tumor size 8.627 0.003
  <4cm 60 (46.2) 70 (53.8) 130
  ≥4cm 71 (65.1) 38 (34.9) 109
Vascular invasion 0.291 0.589
 Yes 53 (57.0) 40 (43.0) 93
 No 78 (53.4) 68 (46.7) 146
Parametrial infiltration 5.459 0.019
  Yes 17 (73.9) 6 (26.1) 23
  No 11 (52.8) 102 (47.2) 216
Histological subtype 0.311 0.577
  Squamous cell carcinoma 112 (54.1) 95 (45.9) 207
  Adenocarcinoma 19 (59.4) 13 (40.6) 32
Histopathologic grade 2.463 0.292
  G1 31 (46.3) 36 (53.7) 67
  G2 43 (38.7) 68 (61.3) 111
  G3 20 (32.8) 41 (67.2) 61
Depth of cervical stromal invasion 6.130 0.013
  <1/2 59 (47.2) 66 (53.8) 125
  ≥1/2 72 (63.2) 42 (36.8) 114
FIGO stage 8.988 0.003
  I 71 (47.0) 80 (53.0) 151
  II 60 (67.0) 28 (37.0) 88
Lymph node metastasis 0.258 0.612
  Yes 20 (58.8) 14 (41.2) 34
  No 111 (54.1) 94 (45.9) 205